Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
Journal Information
Full Title: Turk J Haematol
Abbreviation: Turk J Haematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of Interest: No conflict of interest was declared by the authors."
Funding Disclosure
Evidence found in paper:
"This study was supported by Janssen Pharmaceutica Turkey. The authors would like to thank Prof. Şule Oktay, MD, PhD, and Çağla Ayhan, MD, from KAPPA Consultancy Training Research Ltd. (İstanbul, Turkey), who provided editorial support. Financial Disclosure: The authors declared that this study received no financial support."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025